Vistra’s 6.35% drop on October 8 was less a verdict on one day’s news than a reminder that expectations had moved quickly. The shares had risen 20.5% over the previous five sessions, helped by enthusiasm for power demand and a conditional federal loan commitment of up to $4.2 billion for nuclear plants in Ohio and Pennsylvania. The November 6 third-quarter report now has to show that the operating outlook can support that enthusiasm.
The company’s recent earnings pattern explains why revenue alone may be a poor scorecard. In four of the five quarters reviewed by TIKR, revenue missed consensus by 10% to 27%, yet EBITDA beat in four of those periods. In the second quarter, revenue was $4.02 billion against roughly $5.52 billion expected, while EBITDA on TIKR’s basis reached $1.74 billion, about $100 million above consensus. Vistra’s hedging and generation mix can make reported revenue noisy, so cash-generating operating profit and forward guidance carry more weight.
The Texas question
For the third quarter, the source cited consensus revenue near $7.3 billion and EBITDA around $2.1 billion, increases of roughly 46% and 34% from a year earlier. Those estimates are useful reference points, but the harder question concerns 2027. Management said in August that ERCOT forward power prices for 2027 were meaningfully below the curves used in an October 2025 forecast. Vistra nevertheless kept its 2027 adjusted EBITDA target, implying that stronger PJM capacity revenue, hedges and contracted demand could absorb some Texas weakness.
Management also expects new ERCOT load to connect mainly in 2027 and 2028, not immediately. That timing matters because the market is valuing Vistra partly as a beneficiary of data-center electricity demand. A convincing report would show signed load commitments, the pace of interconnections and how much power-price risk is already hedged, rather than relying on a broad demand narrative.
Capital allocation is the second test. Vistra said its forecast indicated more than $10 billion of available cash in 2026 and 2027, leaving an estimated $2 billion to $2.5 billion unallocated after planned buybacks, dividends and growth spending. Investors should look for a clear bridge from EBITDA to free cash flow, plus details on the cost and conditions of the federal nuclear financing.
Vistra’s second-quarter release showed that operating availability remained high during extreme summer conditions. On November 6, the more decisive evidence will be whether that reliability, capacity pricing and customer contracts can keep 2027 profit guidance intact despite weaker Texas curves.